Patterns and predictors of persistent opioid use following hip or knee arthroplasty

Citation:

Kim SC, Choudhry N, Franklin JM, Bykov K, Eikermann M, Lii J, Fischer MA, Bateman BT. Patterns and predictors of persistent opioid use following hip or knee arthroplasty. Osteoarthritis Cartilage 2017;25:1399-1406.
PDF633 KB

Date Published:

Apr 19

Abstract:

OBJECTIVE: The relationship between arthroplasty and long-term opioid use in patients with knee or hip osteoarthritis is not well studied. We examined the prevalence, patterns and predictors of persistent opioid use after hip or knee arthroplasty. METHOD: Using claims data (2004-2013) from a US commercial health plan, we identified adults who underwent hip or knee arthroplasty and filled >/=1 opioid prescription within 30 days after the surgery. We defined persistent opioid users as patients who filled >/=1 opioid prescription every month during the 1-year postoperative period based on group-based trajectory models. Multivariable logistic regression was used to determine preoperative predictors of persistent opioid use after surgery. RESULTS: We identified 57,545 patients who underwent hip or knee arthroplasty. The mean +/- SD age was 61.5 +/- 7.8 years and 87.1% had any opioid use preoperatively. Overall, 7.6% persistently used opioids after the surgery. Among patients who used opioids in 80% of the time for >/=4 months preoperatively (n = 3023), 72.1% became persistent users. In multivariable analysis, knee arthroplasty vs hip, a longer hospitalization stay, discharge to a rehabilitation facility, preoperative opioid use (e.g., a longer duration and greater dosage and frequency), a higher comorbidity score, back pain, rheumatoid arthritis, fibromyalgia, migraine and smoking, and benzodiazepine use at baseline were strong predictors for persistent opioid use (C-statistic = 0.917). CONCLUSION: Over 7% of patients persistently used opioids in the year after hip or knee arthroplasty. Given the adverse health effects of persistent opioid use, strategies need to be developed to prevent persistent opioid use after this common surgery.

Notes:

1522-9653Kim, S CChoudhry, NFranklin, J MBykov, KEikermann, MLii, JFischer, M ABateman, B TR01 AR069557/AR/NIAMS NIH HHS/United StatesJournal ArticleEnglandOsteoarthritis Cartilage. 2017 Apr 19. pii: S1063-4584(17)30959-7. doi: 10.1016/j.joca.2017.04.002.

Last updated on 02/02/2018